Metabolomic Profiling for Histologically Fibrotic Stage in Chronic Drug-Induced Liver Injury
Background and aims: Chronic drug-induced liver injury (DILI) is a rare but under-researched adverse drug reaction-related disease, which is highly likely to progress into liver fibrosis and even cirrhosis. In this study, metabolomics was used to screen out characteristic metabolites related to the...
Saved in:
Main Authors: | Xian He (Author), Ming-Xi Zhou (Author), Cheng Cheng (Author), Shan-Shan Li (Author), Yuan Gao (Author), Zhi-Tao Ma (Author), Xin-Hua Song (Author), Zhao-Fang Bai (Author), Zheng-Sheng Zou (Author), Xiao-He Xiao (Author), Jia-Bo Wang (Author), Ya-Wen Lu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Screening for Susceptibility-Related Biomarkers of Diclofenac-Induced Liver Injury in Rats Using Metabolomics
by: Can Tu, et al.
Published: (2021) -
Serum metabolomics characteristics and fatty-acid-related mechanism of cirrhosis with histological response in chronic hepatitis B
by: Hai-Na Fan, et al.
Published: (2023) -
Herb-Induced Liver Injury Related to Reynoutria multiflora (Thunb.) Moldenke: Risk Factors, Molecular and Mechanistic Specifics
by: Xing-Ran Zhai, et al.
Published: (2021) -
Association between Metabolic Syndrome and tumor histologic grade and pathologic stage of bladder cancer
by: Shan Jiang, et al.
Published: (2020) -
A metabolome map to conquer fibrotic lung disease
Published: (2022)